Annual Interest Expense
$19.36 M
+$2.88 M+17.49%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual interest expense is $19.36 million, with the most recent change of +$2.88 million (+17.49%) on December 31, 2023.
- During the last 3 years, RVNC annual interest expense has risen by +$4.21 million (+27.78%).
- RVNC annual interest expense is now -33.16% below its all-time high of $28.96 million, reached on December 31, 2012.
Performance
RVNC Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$6.73 M
+$1.05 M+18.54%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly interest expense is $6.73 million, with the most recent change of +$1.05 million (+18.54%) on September 30, 2024.
- Over the past year, RVNC quarterly interest expense has increased by +$1.64 million (+32.18%).
- RVNC quarterly interest expense is now -46.67% below its all-time high of $12.62 million, reached on March 31, 2013.
Performance
RVNC Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$23.07 M
+$1.64 M+7.65%
September 30, 2024
Summary
- As of February 7, 2025, RVNC TTM interest expense is $23.07 million, with the most recent change of +$1.64 million (+7.65%) on September 30, 2024.
- Over the past year, RVNC TTM interest expense has increased by +$5.36 million (+30.24%).
- RVNC TTM interest expense is now -0.47% below its all-time high of $23.17 million, reached on September 30, 2013.
Performance
RVNC TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
RVNC Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.5% | +32.2% | +30.2% |
| 3 y3 years | +27.8% | +328.5% | +153.2% |
| 5 y5 years | +10000.0% | +100.0% | +100.0% |
RVNC Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +208.6% | -2.7% | +328.0% | at high | +267.7% |
| 5 y | 5-year | at high | -100.0% | -2.7% | -100.0% | at high | -100.0% |
| alltime | all time | -33.2% | -100.0% | -46.7% | -100.0% | -0.5% | -100.0% |
Revance Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.73 M(+18.5%) | $23.07 M(+7.6%) |
| Jun 2024 | - | $5.68 M(+8.0%) | $21.43 M(+6.5%) |
| Mar 2024 | - | $5.26 M(-2.6%) | $20.11 M(+3.9%) |
| Dec 2023 | $19.36 M(+17.5%) | $5.40 M(+6.0%) | $19.36 M(+9.3%) |
| Sep 2023 | - | $5.09 M(+16.6%) | $17.71 M(-9.3%) |
| Jun 2023 | - | $4.37 M(-2.9%) | $19.53 M(+2.6%) |
| Mar 2023 | - | $4.50 M(+19.9%) | $19.04 M(+15.6%) |
| Dec 2022 | $16.47 M(+162.6%) | $3.75 M(-45.8%) | $16.47 M(+15.2%) |
| Sep 2022 | - | $6.92 M(+78.5%) | $14.29 M(+59.7%) |
| Jun 2022 | - | $3.87 M(+100.6%) | $8.95 M(+34.7%) |
| Mar 2022 | - | $1.93 M(+22.8%) | $6.64 M(+5.9%) |
| Dec 2021 | $6.27 M(-58.6%) | $1.57 M(+0.1%) | $6.27 M(-31.1%) |
| Sep 2021 | - | $1.57 M(+0.1%) | $9.11 M(-23.3%) |
| Jun 2021 | - | $1.57 M(+0.6%) | $11.87 M(-18.5%) |
| Mar 2021 | - | $1.56 M(-64.6%) | $14.56 M(-3.9%) |
| Dec 2020 | $15.15 M(>+9900.0%) | $4.41 M(+1.8%) | $15.15 M(+41.1%) |
| Sep 2020 | - | $4.33 M(+1.8%) | $10.74 M(+67.7%) |
| Jun 2020 | - | $4.26 M(+98.1%) | $6.40 M(+198.1%) |
| Mar 2020 | - | $2.15 M(>+9900.0%) | $2.15 M(>+9900.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2018 | $44.00 K | $0.00(0.0%) | $44.00 K(-29.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $0.00(0.0%) | $62.00 K(-62.7%) |
| Jun 2018 | - | $0.00(-100.0%) | $166.00 K(-45.9%) |
| Mar 2018 | - | $44.00 K(+144.4%) | $307.00 K(-32.7%) |
| Dec 2017 | $457.00 K(-57.8%) | $18.00 K(-82.7%) | $456.00 K(-31.2%) |
| Sep 2017 | - | $104.00 K(-26.2%) | $663.00 K(-18.7%) |
| Jun 2017 | - | $141.00 K(-26.9%) | $815.00 K(-15.1%) |
| Mar 2017 | - | $193.00 K(-14.2%) | $960.00 K(-11.3%) |
| Dec 2016 | $1.08 M(-9.1%) | $225.00 K(-12.1%) | $1.08 M(-10.8%) |
| Sep 2016 | - | $256.00 K(-10.5%) | $1.21 M(-9.9%) |
| Jun 2016 | - | $286.00 K(-9.2%) | $1.35 M(+0.5%) |
| Mar 2016 | - | $315.00 K(-11.5%) | $1.34 M(+12.6%) |
| Dec 2015 | $1.19 M(-88.8%) | $356.00 K(-8.7%) | $1.19 M(+1.7%) |
| Sep 2015 | - | $390.00 K(+39.8%) | $1.17 M(+16.1%) |
| Jun 2015 | - | $279.00 K(+69.1%) | $1.01 M(+1.2%) |
| Mar 2015 | - | $165.00 K(-50.9%) | $996.00 K(-90.7%) |
| Dec 2014 | $10.67 M(-29.6%) | $336.00 K(+47.4%) | $10.67 M(-11.3%) |
| Sep 2014 | - | $228.00 K(-14.6%) | $12.03 M(-1.0%) |
| Jun 2014 | - | $267.00 K(-97.3%) | $12.16 M(-1.8%) |
| Mar 2014 | - | $9.84 M(+479.6%) | $12.38 M(-18.4%) |
| Dec 2013 | $15.16 M(-47.6%) | $1.70 M(+383.8%) | $15.16 M(-34.6%) |
| Sep 2013 | - | $351.00 K(-28.4%) | $23.17 M(+1.5%) |
| Jun 2013 | - | $490.00 K(-96.1%) | $22.82 M(+2.2%) |
| Mar 2013 | - | $12.62 M(+30.0%) | $22.33 M(+130.0%) |
| Dec 2012 | $28.96 M(+62.8%) | $9.71 M | $9.71 M |
| Dec 2011 | $17.79 M | - | - |
FAQ
- What is Revance Therapeutics annual interest expense?
- What is the all time high annual interest expense for Revance Therapeutics?
- What is Revance Therapeutics annual interest expense year-on-year change?
- What is Revance Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Revance Therapeutics?
- What is Revance Therapeutics quarterly interest expense year-on-year change?
- What is Revance Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Revance Therapeutics?
- What is Revance Therapeutics TTM interest expense year-on-year change?
What is Revance Therapeutics annual interest expense?
The current annual interest expense of RVNC is $19.36 M
What is the all time high annual interest expense for Revance Therapeutics?
Revance Therapeutics all-time high annual interest expense is $28.96 M
What is Revance Therapeutics annual interest expense year-on-year change?
Over the past year, RVNC annual interest expense has changed by +$2.88 M (+17.49%)
What is Revance Therapeutics quarterly interest expense?
The current quarterly interest expense of RVNC is $6.73 M
What is the all time high quarterly interest expense for Revance Therapeutics?
Revance Therapeutics all-time high quarterly interest expense is $12.62 M
What is Revance Therapeutics quarterly interest expense year-on-year change?
Over the past year, RVNC quarterly interest expense has changed by +$1.64 M (+32.18%)
What is Revance Therapeutics TTM interest expense?
The current TTM interest expense of RVNC is $23.07 M
What is the all time high TTM interest expense for Revance Therapeutics?
Revance Therapeutics all-time high TTM interest expense is $23.17 M
What is Revance Therapeutics TTM interest expense year-on-year change?
Over the past year, RVNC TTM interest expense has changed by +$5.36 M (+30.24%)